Supplemental Table S1 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials

Type: Preprint

Publication Date: 2024-08-20

Citations: 0

DOI: https://doi.org/10.1158/2767-9764.26788860.v1

Similar Works

Action Title Year Authors
+ Supplemental Table S1 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S1 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S1 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S7 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S7 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S7 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S7 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S6 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S6 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S6 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S6 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Table 2 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Table 2 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S4 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S4 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S4 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S4 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S5 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S5 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel
+ Supplemental Table S5 from Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials 2024 Esther J. Beck
Alexander D. Sherry
Marcus A. Florez
Ramez Kouzy
Joseph Abi Jaoude
Timothy A. Lin
Avital M. Miller
Adina H. Passy
Gabrielle S. Kupferman
Roshal R. Patel

Works That Cite This (0)

Action Title Year Authors

Works Cited by This (0)

Action Title Year Authors